-20°C for long-term preservation, keep in dry and avoid sunlight. Avoid repeated freezing and thawing.
Soluble in water, DMSO and DMF. Freshly prepared before use.
mPEG-SAA is a succinimide acetate activated PEG derivative. Modification of peptides, proteins, lipids or other small molecule drugs can increase their sustained release time and can also be used for targeted administration.
1. Chan, Peggy, et al. Synthesis and characterization of chitosan-g-poly (ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials, 2007, 28(3): 540-549. 2. Zappe, H., M. E. Snell, and M. J. Bossard. PEGylation of cyanovirin-N, an entry inhibitor of HIV. Advanced drug delivery reviews, 2008, 60(1): 79-87.